Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Lysyl oxidase-like 2 as a predictor of hepatocellular carcinoma in patients with hepatitis C virus after sustained virological response ; volume:14 ; number:1 ; day:13 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (13.5.2024), 1-12, 12.2024
- Creator
-
Chida, Takeshi
Ohta, Kazuyoshi
Noritake, Hidenao
Matsushita, Masahiro
Murohisa, Gou
Kageyama, Fujito
Sasada, Yuzo
Oyaizu, Tatsuki
Tsugiki, Minoru
Tamakoshi, Katsutoshi
Nakajima, Takeyuki
Suda, Takafumi
Kawata, Kazuhito
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-61366-y
- URN
-
urn:nbn:de:101:1-2407222106517.713331123127
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chida, Takeshi
- Ohta, Kazuyoshi
- Noritake, Hidenao
- Matsushita, Masahiro
- Murohisa, Gou
- Kageyama, Fujito
- Sasada, Yuzo
- Oyaizu, Tatsuki
- Tsugiki, Minoru
- Tamakoshi, Katsutoshi
- Nakajima, Takeyuki
- Suda, Takafumi
- Kawata, Kazuhito
- SpringerLink (Online service)
Other Objects (12)
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Hepatitis delta: virological and clinical aspects
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Hepatitis delta: virological and clinical aspects
Risk factors for sustained virological non-suppression among children and adolescents living with HIV in Zimbabwe and Malawi: a secondary data analysis
Sustained virological response 12 versus sustained virological response 24 as evaluation endpoints in chronic hepatitis C virus Egyptian patients treated with sofosbuvir-based regimens
Sustained virological response in HIV/HCV co-infected patients without rapid virological response (RVR) on peginterferon-ribavirin therapy
Hepatitis C virus core antigen, an earlier and stronger predictor on sustained virological response in patients with genotype 1 HCV infection
Ongoing liver inflammation in patients with chronic hepatitis C and sustained virological response
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
Economic evaluation of hepatocellular carcinoma surveillance in chronic hepatitis B patients with virological remission
Effect of sustained virological response after direct-acting antivirals on liver fibrosis in patients with chronic HCV infection
Evolution of CD4+ T-cell count in HIV-1 infected adults receiving antiretroviral therapy with sustained long-term virological suppression
The impact of achieving a sustained virological response with direct-acting antivirals on serum autotaxin levels in chronic hepatitis C patients
Hepatitis delta: virological and clinical aspects